Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Nanomedicine
(ISSN: 1743-5889,1748-6963)
This journal no longer participates in Medscape Publishers' Circle Program. No new articles will be republished.
Gold nanoparticles are proving to be an excellent x-ray contrast agent due to their high x-ray attenuation and nontoxicity. What is required for their efficient use in clinical applications?
Cancer stem cells can cause drug resistance, cancer relapse and metastasis. How might nanocarriers be employed for targeting cancer stem cells for improved cancer therapy?
Tumor-targeted therapies using monoclonal antibodies has revolutionized cancer chemotherapy, but challenges still exist. How might nanobody-based therapeutics overcome these limitations?
The authors developed a stable nanoemulsion for the administration of the hydrophobic antiobesity agent N-oleoylethanolamide, which could be applicable to other drugs with low solubility in water.
An in vitro platform for elucidating the molecular genetics of S. aureus invasion of the osteocyte lacuno-canalicular network during chronic osteomyelitis.
Corrigendum to "A rationally designed photo-chemo core-shell nanomedicine for inhibiting the migration of metastatic breast cancer cells followed by photodynamic killing" [Nanomedicine: Nanotechnology, Biology, and Medicine, 2014;10(3):579-87].
Mission Statement:
Nanomedicine is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics.
